Analysis of the clinical application of ceftazidime-avibactam in China
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine
Reference27 articles.
1. Treatment options for carbapenem-resistant gram-negative bacterial infections;Doi;Clin Infect Dis,2019
2. (CDC), Centers for Disease Control and Prevention. Clinicians: Information about CRE, 2019. [2020–12-09] [〈https://www.cdc.gov/hai/organisms/cre/cre-clinicians.html〉].
3. Diazabicyclooctanes (DBOs): a potent new class of non-beta-lactam beta-lactamase inhibitors;Coleman;Curr Opin Microbiol,2011
4. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and pseudomonas aeruginosa AmpC beta-lactamases;Lahiri;Antimicrob Agents Chemother,2013
5. Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by klebsiella pneumoniae carbapenemase-producing K. pneumoniae;Tumbarello;Clin Infect Dis,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ceftazidime-Avibactam as a Salvage Treatment for Severely Infected Immunosuppressed Children;Drug Design, Development and Therapy;2024-07
2. The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes;Antibiotics;2024-03-16
3. Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India;Cureus;2024-02-19
4. Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study;Infection and Drug Resistance;2024-01
5. Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis;Microbial Pathogenesis;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3